Skip to content

Clinical trials

Glucose Metabolism Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20068
20081
20091
20102
20182
20191
20202
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Solvay Pharmaceuticals3
AstraZeneca2
Eli Lilly and Company2
Pfizer2
Katarzyna Siedzik1
ModernaTX, Inc.1
Poznan University of Medical Sciences1
University of Warmia and Mazury in Olsztyn1
Wroclaw University of Health and Sport Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders23
Diabetes Mellitus, Type 215
Diabetes Mellitus14
Dyslipidemias12
Metabolic Diseases7
Endocrine System Diseases6
Obesity4
Body Weight3
Metabolic Syndrome3
Nutrition Disorders3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.